Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C

I D Steven1, J S Gill, R Hall

  • 1Research and Health Promotion Unit, RACGP, St Peters, South Australia.

Australian Family Physician
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Hepatitis C virus (HCV) disproportionately affects injecting drug users and is often asymptomatic. While prevention is key, alpha interferon shows potential therapeutic benefits for up to 30% of individuals with active infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maternal immune memory and sex differences in living donor kidney transplant outcomes.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

WolffParkinsonWhite syndrome and persistent azygous drainage of the inferior vena cava.

BMJ case reports·2025
Same author

The prevalence of Chlamydia trachomatis infection by Nucleic Acid Amplification test in women of reproductive age group under treatment for infertility.

Medical journal, Armed Forces India·2024
Same author

Gut microbiota profiling in hematopoietic stem cell transplant recipients: Towards personalized medicine.

Medical journal, Armed Forces India·2021
Same author

Blueprinting of summative theory assessment of undergraduate medical students in microbiology.

Medical journal, Armed Forces India·2020
Same author

Reciprocity to Increase Participation of Compatible Living Donor and Recipient Pairs in Kidney Paired Donation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same journal

Occupational violence and staff safety in general practice.

Australian family physician·2018
Same journal

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Australian family physician·2018
Same journal

Understanding the decision to commence a dose administration aid.

Australian family physician·2018
Same journal

Psychological distress and risky sexual behaviours among women aged 16-25 years in Victoria, Australia.

Australian family physician·2018
Same journal

A mixed-methods feasibility study of routinely weighing patients in general practice to aid weight management.

Australian family physician·2018
Same journal

The Australian Mid-West Coastal Marine Wound Infections Study.

Australian family physician·2018
See all related articles

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Injecting drug use is a primary risk factor for HCV transmission.
  • HCV often presents asymptomatically, delaying diagnosis and treatment.

Purpose of the Study:

  • To summarize the epidemiology and clinical outcomes of Hepatitis C.
  • To discuss the challenges in managing HCV infection.
  • To highlight potential treatment options for active HCV infection.

Main Methods:

  • Literature review of Hepatitis C prevalence and impact.
  • Analysis of asymptomatic infection rates.
  • Evaluation of treatment efficacy for Hepatitis C.

Related Experiment Videos

Main Results:

  • HCV is highly prevalent in the injecting drug user population.
  • Over 50% of HCV infections are asymptomatic.
  • A substantial percentage of infected individuals develop severe liver disease, including cirrhosis and liver cancer.

Conclusions:

  • HCV poses a serious risk to injecting drug users, often progressing silently to severe liver disease.
  • Early prevention strategies are crucial for controlling HCV.
  • Alpha interferon may offer therapeutic benefits for a subset of patients with active Hepatitis C infection.